Cross-sectional Study to Characterize Real World Burden of Disease in Patients With Vitiligo in China

Cross-sectional Study to Characterize Real World Burden of Disease in Patients With Vitiligo in China

The purpose of this study is to evaluate the patterns of treatment, healthcare resources utilized and the burdens associated with non-segmental vitiligo (NSV) amongst participants in China

This study is a cross-sectional, multicenter, observational study of vitiligo patients in China. The cross-sectional design is sufficient to characterize the overall current burden of NSV.

Cross-Sectional

Inclusion Criteria:

• Male and female patients, age ≥ 12.
• Chinese patients meet the diagnosis of Non-Segmental Vitiligo (NSV) and 5≤ Total Vitiligo Area Scoring Index (T-VASI<50) with or without facial involvement.
• Medical history available within the last 6 months.
• Ability to understand the questionnaires, with parental support as required for adolescents (between ≥ 12 and < 18 years of age at inclusion visit).
• Willing to provide a patient authorization form to use and disclose personal health information (or informed consent, where applicable) to participate in the study; for adolescent subjects, authorization and/or consent will be provided by a parent or legal guardian, where applicable.

Exclusion Criteria:

• Unable or unwilling to comply with study requirements and electronic Patient-Reported Outcome (ePRO) collection.
• Segmental or localized vitiligo.
• Greater than 33% leukotrichia in areas of vitiligo on the face or on the body.
• History of active skin disease other than vitiligo that could interfere with the assessment of vitiligo.
• Patients who are participating in interventional clinical trial(s) at time of study visit.
• Patients who are currently receiving treatment with any investigational drug/device/intervention or have received any investigational product within 1 month or 5 half-lives of the investigational agent (whichever is longer) prior to enrollment.